|
August 4, 2006 Vol. 1, Issue 2
Welcome Back!
Earlier this year, the media deployed the best and brightest from the science world to discuss the imminent threat of Bird Flu mutating into a form that would allow for human-to-human infection. ABC News produced a special report on world-renowned researcher Dr. Robert G. Webster, who stated: "Society just can't accept the idea that 50 percent of the population could die, and I think we have to face that possibility." However, as time passed, the public became distracted by multiple wars in the Middle East, inflation, rising oil prices, tumbling financial markets, global warming, and a host of other issues. Unfortunately, evolving evidence underscores the reality that Bird Flu, otherwise know as H5N1 Avian Influenza, is still a very real threat. Influenza is already a big killer, as it is responsible for more than 35,000 deaths and more than 200,000 hospitalizations in the United States each year. Avian flu occurs naturally in birds and has historically demonstrated the ability to infect humans. It already is unprecedented as an animal illness in its rapid expansion, and has cost 300 million farmers more than $15 billion during its recent spread in poultry around the globe. World Health Organization (WHO) officials claim the H5N1 strain of Avian Flu poses a greater challenge to the world than any other infectious disease, including AIDS. As of July 20th, WHO officials confirm that of the 230 individuals known to have been infected, 132 died since the virus re-emerged in 2003. More.
Research Notes
Flu Vaccine: Is the Cure Worse than the Disease? by Tom Reynolds Have you had your flu shot lately? If so, you probably had a good experience as did the vast majority of your fellow flu shot recipients. For five bucks you got immunity to the flu this year. The only likely side effect was a sore arm - and even that can be avoided thanks to the newly available FluMist nasal flu vaccine. But an unlucky few suffered side effects. Between 5 to 10 percent of all people immunized experience "adverse events" -- to use the terminology of the vaccine development world -- including mild to moderate flu-like symptoms. But an unlucky few suffered side effects. Between 5 to 10 percent of all people immunized experience "adverse events" -- to use the terminology of the vaccine development world -- including mild to moderate flu-like symptoms. If the cure causes the misery you were trying to avoid in the first place, some folks wonder, "What's the point getting vaccinated?" Well, according to the Centers for Disease Control, getting the shot drastically reduces the chance of getting serious complications from the flu. The vaccination is highly recommended for anyone over 65 or for anyone caring for an immuno-compromised person.
Q&A with Joseph Chimera
Joe, what in your background best addresses our need to grow commercial revenue? There are several points. First, as you know from my resume, I have extensive training in modern molecular biology, including an advanced degree and post-doctoral training. I know the technology. More |
Commonwealth Biotechnologies, Inc., collaborates with clients to solve complex laboratory testing problems at its secure, state-of-the-art facilities in Richmond, Va. Newsletter Company Profile Expertise The TechnologiesOther CBI Websites
Investor Relations Commonwealth Biotechnologies, Inc., Signs a Term Sheet with PharmAust, Ltd., to Acquire Mimotopes, Pty. Ltd. CBI announced today that it has signed a non-binding term sheet to acquire the outstanding capital stock of Mimotopes Pty., Ltd., a wholly owned subsidiary of PharmAust Ltd. July 26, 2006. More. CBI Appoints Dr. Joseph Chimera as new Senior Vice President, Sales Marketing, and Business Development. Aethlon Medical and CBI sign cooperative research agreement to expand uses of Aethlon's "HemopurifierTM" to Biothreat Agents. Aethlon Medical, Inc., a pioneer in developing therapeutic devices for infectious disease, announced today that it has signed a cooperative research agreement with Commonwealth Biotechnologies, Inc. March 29, 2006. Links to the Past and Present 2005 Annual Report (pdf)2006 Shareholders Meeting (ppt) Press Releases Newsletter back IssuesContact |
